Endurance RP Ltd
F:RPG

Watchlist Manager
Endurance RP Ltd Logo
Endurance RP Ltd
F:RPG
Watchlist
Price: 0.01 EUR Market Closed
Market Cap: 82.3k EUR

Relative Value

RPG price has not been updated for more than 6 years. This may indicate that the stock has been delisted.

The Relative Value of one RPG stock under the Base Case scenario is 0.001 EUR. Compared to the current market price of 0.01 EUR, Endurance RP Ltd is Overvalued by 93%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RPG Relative Value
Base Case
0.001 EUR
Overvaluation 93%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
58
vs Industry
5
Median 3Y
45.1
Median 5Y
48.1
Industry
2.6
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-1
Industry
21.7
vs History
vs Industry
13
Median 3Y
-4.1
Median 5Y
-12.3
Industry
16.7
vs History
11
vs Industry
8
Median 3Y
-5.1
Median 5Y
-10.9
Industry
23.1
vs History
vs Industry
55
Median 3Y
-2.9
Median 5Y
1.2
Industry
2.2
vs History
55
vs Industry
4
Median 3Y
44
Median 5Y
51.9
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-4.6
Industry
13.2
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-1.1
Industry
16.8
vs History
vs Industry
18
Median 3Y
-4.3
Median 5Y
-10
Industry
15.9
vs History
vs Industry
16
Median 3Y
-4.3
Median 5Y
-10
Industry
19.2
vs History
vs Industry
65
Median 3Y
-4.3
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

RPG Competitors Multiples
Endurance RP Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Endurance RP Ltd
F:RPG
286m EUR 40.2 -9 -9.7 -9.7
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55 36.9 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
496.6B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.2 108.4 158.7
CH
Novartis AG
SIX:NOVN
208.2B CHF 4.7 18.2 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.4B USD 3.9 13.2 9.4 11.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
HK
Endurance RP Ltd
F:RPG
Average P/E: 24
Negative Multiple: -9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
Endurance RP Ltd
F:RPG
Average EV/EBITDA: 438.8
Negative Multiple: -9.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
HK
Endurance RP Ltd
F:RPG
Average EV/EBIT: 1 881.3
Negative Multiple: -9.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.2
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3